GlobalData
GlobalData

Medical Devices

Johnson and Johnson’s Q3 results bode well for rapid medical device sales recovery in Q4 and into 2021

Following the recent release of Johnson and Johnson’s Q3 2020 financial results; Dominic Tong, Medical Device Analyst at GlobalData, a leading data and analytics company, offers his view: “Johnson and Johnson’s better than-expected-performance across multiple segments is reflective of the quick recovery seen across medical device manufacturers. “While the company’s Q3 medical device sales were […]
Read more

Republican Party platform offers both advantages and drawbacks to medical device market,

The 2020 US presidential election has garnered heavy political pressure on the fast-tracked approval of a COVID-19 vaccine, where several attempts have been made to block the Food and Drug Administration (FDA) from releasing stricter guidelines that will push the approval past Election Day. While a speedier approval process can be beneficial to the development of innovative […]
Read more

APAC neurovascular thrombectomy devices market to witness 6% growth through 2025, forecasts GlobalData

The neurovascular thrombectomy devices market in the Asia-Pacific (APAC) region is expected to grow at a compound annual growth rate (CAGR) of about 6% between 2020 and 2025, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Neurovascular Thrombectomy Devices (Neurology Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact)‘, reveals […]
Read more

Indonesia should see COVID-19 pandemic as opportunity to strengthen medical devices sector, says GlobalData

Lack of adequate healthcare infrastructure and dependency on other countries for medical supplies made it difficult for Indonesia to tackle the COVID-19 pandemic effectively. The country should turn the crisis into an opportunity and create strategies to strengthen its medical device sector, according to GlobalData, a leading data and analytics company. Pratibha Thammanabhatla, Medical Devices […]
Read more

Price cap extension on knee implants will drive growth in India

To provide relief to patients undergoing orthopedic surgery requiring knee implants, the National Pharmaceutical Pricing Authority (NPPA) extended the timeline of price cap on these devices by one more year. The move is likely to drive the sale of knee implants in India, says GlobalData, a leading data and analytics company. GlobalData’s report Knee Reconstruction (Orthopedic Devices) – Global […]
Read more

Smith & Nephew strengthens presence in global orthopedic market with acquisition of Integra’s Extremity Orthopaedics business

Following the announcement that Smith & Nephew has acquired the Extremity Orthopaedics business of Integra LifeSciences for $240m; Kamilla Kan, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers her view on this deal: “According to GlobalData, over 71% of Integra LifeSciences’ net sales are across business segments from North America. By […]
Read more

The growth of global insulin pen market decelerates to 2.3% in 2020 due to COVID-19

The insulin delivery market has been negatively affected by the major upheavals experienced in diabetic care due to COVID-19. The insulin pen market, which was seeing a compound annual growth rate (CAGR) of 5.1% prior to COVID-19, according to leading data and analytics company GlobalData, has now decreased to show 2.3% growth in 2020 due to new patient start delays from physician […]
Read more

COVID-19 pandemic impacting robotic surgical systems market with 7.7% lost revenue expected in 2020

Nearly 8% of revenue from robotic surgical systems will be lost in 2020 due to COVID-19, according to GlobalData, a leading data and analytics company, as many elective robotic surgical procedures have been postponed. Given that Intuitive Surgical is the market leader for robotic surgical systems sales, most revenue lost during the COVID-19 pandemic will be experienced by this company. For […]
Read more

TachoSil acquisition gives Corza Health significant foothold in tissue sealants market, says GlobalData

Takeda Pharmaceutical has recently agreed to sell TachoSil Fibrin Sealant Patch to California-based Corza Health for EUR350m (US$413m). The acquisition will provide Corza Health a significant foothold in the growing tissue sealants market, says GlobalData, a leading data and analytics company. TachoSil divestiture is in line with Takeda’s goal of exiting non-core businesses, lowering debt […]
Read more
1 38 39 40 41 42 50